2020
DOI: 10.1016/j.jpha.2019.11.003
|View full text |Cite
|
Sign up to set email alerts
|

Vancomycin pretreatment attenuates acetaminophen-induced liver injury through 2-hydroxybutyric acid

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
20
0

Year Published

2021
2021
2025
2025

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(20 citation statements)
references
References 33 publications
0
20
0
Order By: Relevance
“…Zheng et al changed the composition of the gut microbiota in mice using vancomycin, which reduced the abundance of Gram-positive bacteria in the intestine and increased the level of 2-hydroxybutyric acid in the cecum and serum. The bioavailability of APAP was also decreased and the level of GSH in the liver was increased, which improved the APAP-induced liver injury in mice (Zheng et al, 2020 ). The pharmacokinetics of APAP is also affected by changing the composition of gut bacteria in mice.…”
Section: The Gut Microbiota and Apap-induced Liver Injurymentioning
confidence: 99%
“…Zheng et al changed the composition of the gut microbiota in mice using vancomycin, which reduced the abundance of Gram-positive bacteria in the intestine and increased the level of 2-hydroxybutyric acid in the cecum and serum. The bioavailability of APAP was also decreased and the level of GSH in the liver was increased, which improved the APAP-induced liver injury in mice (Zheng et al, 2020 ). The pharmacokinetics of APAP is also affected by changing the composition of gut bacteria in mice.…”
Section: The Gut Microbiota and Apap-induced Liver Injurymentioning
confidence: 99%
“…Nrf-2 is a transcription factor that improves redox defense by endorsing the transcriptions of antioxidant enzymes, thus exhibiting protection against APAP toxicity [ 73 ]. In another report, Zheng and colleagues (2020) showed that a reduction in gram-positive count in the intestine by vancomycin treatment in experimental mice could increase the 2-hydroxybutyric acid level in the cecum and serum, resulting in a decrease in APAP bioavailability and an increase in GSH level to ameliorate APAP hepatotoxicity [ 74 ]. Thus, the pharmacokinetics of APAP can be affected by changes in the abundance, and/or diversity, of gut microbiota.…”
Section: Emerging Role Of the Gut Microbiota In Apap Hepatotoxicitymentioning
confidence: 99%
“…Similarly, the changes in intestinal flora diversity and abundance could also affect the metabolism of APAP. Vancomycin decreased the bioavailability of APAP after changing the composition of intestinal microflora in mice, thereby alleviating the liver injury of APAP [7]. The pharmacokinetics of APAP was also affected by the changes in intestinal bacterial composition in mice.…”
Section: Introductionmentioning
confidence: 99%